SFRP2 may participate in cardiac diseases through myocardial fibrosis and abnormalities of cardiac function mechanisms, but clinical data directly linking SFRP2 to HF remain limited.Therefore, this study was conducted to verify whether SFRP2 can provide additional prognostic information for heart failure patients, independent of NT-proBNP. Here, NPPB is linked to heart failure.